Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
KROS
#2417
Keros Therapeutics, Inc. Common Stock
14.190
0
-3.14%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-3.14%
Monthly Change
-21.86%
6 month change
-6.03%
Cambio anual
-6.03%
Cierres anteriores
14.650
0
Open
14.190
0
Bid
Ask
Low
14.190
0
High
14.190
0
Volumen
60
Markets
Acciones
Atención Sanitaria
KROS
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Noticias
Keros Therapeutics suma exdirector financiero de Lyell a su consejo
Should Investors Buy, Sell or Hold KROS Stock Ahead of Q4 Earnings?
Will Reblozyl Shine in Bristol Myers' Fourth-Quarter Results?
SRPT Stock Up 8% on Positive Long-Term Data From Elevidys Study in DMD
Keros Therapeutics vs. Dyne: Which DMD Biotech Has More Upside?
Is KROS' KER-065 the Next Breakthrough in DMD Space?
JANX Enters Global Oncology Collaboration With BMY, Stock Rises
Ionis' Dawnzera Gets EU Approval for Hereditary Angioedema
MRKR Stock Up Nearly 114% in 3 Months: Here's What You Need to Know
Novartis' Ianalumab Wins Breakthrough Therapy Tag for Sjogren's Disease
Axsome Therapeutics Begins Phase III Study on AXS-14 for Fibromyalgia
Will KROS Stock's Restructuring Efforts Reap Rewards for Investors?